Globus Medical (GMED) Depreciation & Amortization (CF) (2011 - 2026)

Globus Medical (GMED) has 16 years of Depreciation & Amortization (CF) data on file, last reported at $69.9 million in Q1 2026.

• Quarterly Depreciation & Amortization (CF) rose 6.4% year-over-year to $69.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $281.0 million (up 6.54% YoY) and the FY2025 annual result came in at $276.8 million, up 9.26% from the prior year.
• Depreciation & Amortization (CF) climbed to $69.9 million in Q1 2026, from $69.0 million in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $72.0 million in Q4 2023 to a low of $16.8 million in Q1 2022.
• A 5-year average of $47.9 million and a median of $63.6 million in 2024 frame the typical range for Depreciation & Amortization (CF).
• Annual changes were most pronounced in 2022 — Depreciation & Amortization (CF) slipped 11.52% — and 2023, when it jumped 325.52%.
• Tracing GMED's Depreciation & Amortization (CF) over 5 years: stood at $16.9 million in 2022, then surged by 325.52% to $72.0 million in 2023, then retreated by 6.06% to $67.6 million in 2024, then rose by 2.1% to $69.0 million in 2025, then gained by 1.22% to $69.9 million in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $69.9 million (Q1 2026), $69.0 million (Q4 2025), and $71.1 million (Q3 2025), per Business Quant data.